"In such a short period of time, many international scientific research problems in the field of tumor immunity have been overcome. This is due to the strong boost of the 'Medical and Health Technology Innovation Project'. These results will transform the new tumor immunotherapy technology and immunotherapy in the future. The drug laid an important foundation.†On March 14, at the press conference of the Chinese Academy of Medical Sciences Medical Health and Technology Innovation Project, Professor Huang Bo, deputy director of the Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences, said. Since December last year, Huang Bo’s research team has published a series of high-quality academic papers in internationally renowned academic journals, including relevant research results on anti-procedural death protein 1 (PD-1) immunotherapy. On March 12th, it was published online in the international cancer oncology journal Cancer Cell. The Chinese Academy of Medical Sciences is the only state-level public welfare comprehensive medical research institution in China. Under the support and guidance of the Ministry of Finance and the National Health and Family Planning Commission, the “Medical and Health Technology Innovation Project†was launched in 2016 and was included in the “Healthy China 2030†Plan. "Tumor treatment is a worldwide problem. China has always had a layout for cancer treatment in major projects. This year's government work report also proposed 'strengthening major diseases such as cancer prevention and control'. At present, the international attention is about cancer immunotherapy. "In 2015, the Chinese Academy of Medical Sciences established the Center for Immunotherapy Research. Academician Cao Xuetao, director of the center, said, "The implementation of the innovative project has given steady and strong support to medical research projects, not only laying the foundation for scientific research, but also mobilizing researchers. The spirit of the spirit, combing the ideas of the frontiers, establishing a coordination mechanism, gathering the whole university to work together on major goals. As the innovation project of the Medical Academy, we are mobilizing all forces, such as tumor metastasis and immunity. In the important direction of the relationship, the occurrence of chronic inflammatory diseases and prevention and control; at the same time, we attract creative researchers, especially young talents, to join the international community, improve post-doctoral treatment and support, and stimulate their creative vitality." Wang Jianwei, director of the Science and Technology Management Department of Peking Union Medical College, Chinese Academy of Medical Sciences, said that the next step in the innovation project will be to promote cross-integration by strengthening strategic research, optimizing task layout, strengthening talent introduction, accelerating the construction of base platforms, and promoting international cooperation in science and technology. Reflecting the advantages and characteristics, we will achieve “and run†and “lead run†in the research of medical and health frontier technologies. (Technology Daily, reporter Hualing) Skin Whitening And Spot Removing Material
The products under this category are mainly cosmetic raw materials, the main functions are whitening, lightening, moisturizing, etc.
Shaanxi Haibo Biotechnology Co., Ltd. has R&D, production, quality inspection, sales and other departments.
Shaanxi Haibo Biotechnology Co., Ltd. specializes in the research, production and sales of natural plant extracts used in the cosmetic raw material industry.
Skin Whitening And Spot Removing Material,Alpha Arbutin,Deoxyarbutin,Kojic Acid SHAANXI HAIBO BIOTECHNOLOGY CO., LTD , https://www.rozenbio.com
Medical and health innovation projects boost cancer prevention and treatment